|
Manero RM, Casals-Coll M, Sánchez-Benavides G, Rodríguez-de los Reyes ON, Aguilar M, Badenes D, Molinuevo JL, Robles A, Barquero MS, Antúnez C, Martínez-Parra C, Frank-García A, Fernández M, Blesa R, Peña-Casanova J; NEURONORMA Study Team.. Diagnostic validity of the Alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord. 2014;37(5-6):366-75. doi: 10.1159/000350800. PubMed PMID: 24556708.
AÑO: 2014; IF: 3.547
|
24556708
|
Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A, Rosende-Roca M, Bellenguez C, Bis JC, Harold D, Gerrish A, Sims R, Sotolongo-Grau O, Espinosa A, Alegret M, Arrieta JL, Lacour A, Leber M, Becker J, Lafuente A, Ruiz S, Vargas L, Rodríguez O, Ortega G, Dominguez MA; IGAP., Mayeux R, Haines JL, Pericak-Vance MA, Farrer LA, Schellenberg GD, Chouraki V, Launer LJ, van Duijn C, Seshadri S, Antúnez C, Breteler MM, Serrano-Ríos M, Jessen F, Tárraga L, Nöthen MM, Maier W, Boada M, Ramírez A. Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene. Transl Psychiatry. 2014 Feb 4;4:e358. doi: 10.1038/tp.2014.2. PubMed PMID: 24495969; PubMed Central PMCID: PMC3944635.
AÑO: 2014; IF: 5.62
|
|
Martella D, Manzanares S, Campoy G, Roca J, Antúnez C, Fuentes LJ. Phasic and tonic alerting in mild cognitive impairment: A preliminary study. Exp Gerontol. 2014 Jan;49:35-9. doi: 10.1016/j.exger.2013.11.001. PubMed PMID: 24252535.
AÑO: 2014; IF: 3.485
|
|
Casals-Coll M, Sánchez-Benavides G, Meza-Cavazos S, Manero RM, Aguilar M, Badenes D, Molinuevo JL, Robles A, Barquero MS, Antúnez C, Martínez-Parra C, Frank-García A, Fernández M, Blesa R, Peña-Casanova J; NEURONORMA Study Team.. Spanish multicenter normative studies (NEURONORMA project): normative data and equivalence of four BNT short-form versions. Arch Clin Neuropsychol. 2014 Feb;29(1):60-74. doi: 10.1093/arclin/act085. PubMed PMID: 24217861.
AÑO: 2014; IF: 1.986
|
|
Boada M, Antúnez C, Ramírez-Lorca R, DeStefano AL, González-Pérez A, Gayán J, López-Arrieta J, Ikram MA, Hernández I, Marín J, Galán JJ, Bis JC, Mauleón A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Morón FJ, Velasco J, Carrasco JM, Alegret M, Espinosa A, Vinyes G, Lafuente A, Vargas L, Fitzpatrick AL; Alzheimer’s Disease Neuroimaging Initiative., Launer LJ, Sáez ME, Vázquez E, Becker JT, López OL, Serrano-Ríos M, Tárraga L, van Duijn CM, Real LM, Seshadri S, Ruiz A. ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. Mol Psychiatry. 2014 Jun;19(6):682-7. doi: 10.1038/mp.2013.86. PubMed PMID: 23857120; PubMed Central PMCID: PMC4031637.
AÑO: 2014; IF: 14.496
|